140 related articles for article (PubMed ID: 34570419)
1. Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.
Flitcroft JG; Verheyen J; Vemulkar T; Welbourne EN; Rossi SH; Welsh SJ; Cowburn RP; Stewart GD
BJU Int; 2022 Mar; 129(3):290-303. PubMed ID: 34570419
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
3. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.
Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC
Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161
[TBL] [Abstract][Full Text] [Related]
4. Non-Invasive Diagnostics of Renal Cell Carcinoma Using Ultrasensitive Immunodetection of Cancer-Retina Antigens.
Shlyapnikov YM; Malakhova EA; Potoldykova NV; Svetocheva YA; Vinarov AZ; Zinchenko DV; Zernii EY; Zamyatnin AA; Shlyapnikova EA
Biochemistry (Mosc); 2022 Jul; 87(7):658-666. PubMed ID: 36154884
[TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
7. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
9. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the Detection and Surveillance of Renal Cancer.
Nolazco JI; Soerensen SJC; Chung BI
Urol Clin North Am; 2023 May; 50(2):191-204. PubMed ID: 36948666
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
[TBL] [Abstract][Full Text] [Related]
12. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
13. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
14. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
[TBL] [Abstract][Full Text] [Related]
15. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and prognostic markers of renal cell carcinoma].
Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
[TBL] [Abstract][Full Text] [Related]
17. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
[TBL] [Abstract][Full Text] [Related]
18. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
19. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
20. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
